WGS-guided Tracking and Infection Control Measures of CRKP

Klebsiella Pneumoniae Infection Clinical Trial

Official title:
WGS-guided Tracking and Infection Control Measures of Carbapenem-resistant Klebsiella Pneumoniae

Status Recruiting

Clinical Trial Summary

The objective of this study is to investigate the effect of the infection control measures based on the active screening of carbapenem-resistant Klebsiella pneumoniae and whole-genome based tracking and surveillance though the hospital.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04413305
Study type	Interventional
Source	Huashan Hospital
Contact
Status	Recruiting
Phase	N/A
Start date	May 28, 2020
Completion date	September 30, 2021

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03598543` - Epidemiology of Klebsiella Pneumoniae in China
Completed	`NCT04959344` - Safety and Immunogenicity of a Klebsiella Pneumoniae Tetravalent Bioconjugate Vaccine (Kleb4V)	Phase 1/Phase 2
Not yet recruiting	`NCT03245632` - Epidemiological Characteristics and Treatment Protocol for Carbapenem-Resistant Klebsiella Pneumoniae in China	N/A
Recruiting	`NCT03891433` - Piperacillin/Tazobactam Versus Carbapenems in Non-bacteremic UTI Due to -ESBL-producing Enterobacteriaceae	Phase 4